Skip to main content

Table 3 Risk factors associated with death of children with severe HFMD

From: N-terminal pro-brain natriuretic peptide levels associated with severe hand, foot and mouth disease

Relevant factors

Cure group

n = 83 (%)

Death group

n = 45 (%)

P

Gender (male/female)

51/32

27/18

0.873

Age (≤3 years)

60 (72.3)

39 (86.7)

0.064

Fever

83 (100.0)

45 (100.0)

-

Peak temperature (>39 °C)

69 (83.1)

38 (84.4)

0.848

Hypersomnia

73 (88.0)

45 (100.0)

0.015*

Hyperarousal

79 (95.2)

42 (93.3)

0.661

Limb shaking

60 (72.3)

38 (84.4)

0.121

Convulsion

27 (32.5)

6 (13.3)

0.018

Vomiting

56 (67.5)

31 (68.9)

0.870

Dyspnoea

30 (36.1)

45 (100.0)

-

Pathologic reflexes

83 (100.0)

45 (100.0)

-

Consciousness disorder

30 (36.1)

45 (100.0)

-

Increased blood pressure

20 (24.1)

45 (100.0)

-

Circulatory disturbance

30 (36.1)

45 (100.0)

-

Laboratory examination

 Peripheral WBC count > 15 × 109/L

27 (32.5)

29 (64.4)

0.001**

 Fasting blood glucose level > 8.3 mmol/L

25 (30.1)

37 (21.8)

0.000***

 EV71-positivity

43 (51.8)

32 (71.1)

0.000***

 NT-proBNP (pg/mL)

1435 ± 4201

12776 ± 13115

0.000***

 NT-proBNP (log10 pg/mL)

2.68 ± 0.49

3.79 ± 0.61

0.000***

 Increased CK

13 (15.7)

18 (40.0)

0.002**

 Increased CK-MB

33 (39.8)

25 (55.6)

0.087

 Increased LDH

4 (4.8)

14 (31.1)

0.000***

 Increased PCT

48 (57.8)

23 (51.1)

0.465

  1. HFMD hand, foot, and mouth disease, EV71 enterovirus 71, WBC White blood cell, NT-proBNP N-terminal of the prohormone brain natriuretic peptide, CK Creatine kinase isoenzyme, CK-MB Creatine kinase isoenzyme-MB, LDH Lactate dehydrogenase, PCT procalcitonin, IVIG Intravenous immunoglobulins
  2. *P <0.05, **P <0.01,***P <0.001